Jennison Associates’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3M Sell
121,239
-2,361
-2% -$330K 0.01% 355
2025
Q4
$20.3M Buy
+123,600
New +$19.4M 0.01% 336
2022
Q3
Sell
-76,573
Closed -$12.4M 654
2022
Q2
$12.4M Sell
76,573
-3,582
-4% -$567K 0.01% 369
2022
Q1
$15.1M Sell
80,155
-9,255
-10% -$1.76M 0.01% 380
2021
Q4
$23.7M Buy
89,410
+3,828
+4% +$1.03M 0.02% 335
2021
Q3
$24.7M Buy
85,582
+2,948
+4% +$756K 0.02% 339
2021
Q2
$16.5M Sell
82,634
-110,359
-57% -$21.4M 0.01% 400
2021
Q1
$37.5M Sell
192,993
-1,741
-0.9% -$357K 0.03% 258
2020
Q4
$37.3M Sell
194,734
-1,975
-1% -$359K 0.03% 255
2020
Q3
$29M Buy
196,709
+789
+0.4% +$113K 0.02% 262
2020
Q2
$24.2M Buy
195,920
+1,209
+0.6% +$142K 0.02% 268
2020
Q1
$18.8M Buy
194,711
+1,695
+0.9% +$164K 0.02% 262
2019
Q4
$17.9M Buy
193,016
+1,747
+0.9% +$147K 0.02% 326
2019
Q3
$14.7M Sell
191,269
-19,300
-9% -$1.69M 0.02% 351
2019
Q2
$18.1M Sell
210,569
-440
-0.2% -$30K 0.02% 367
2019
Q1
$12.5M Sell
211,009
-48
-0% -$2.76K 0.01% 415
2018
Q4
$11.1M Buy
211,057
+2,367
+1% +$139K 0.01% 426
2018
Q3
$11.6M Buy
208,690
+1,886
+0.9% +$97.2K 0.01% 459
2018
Q2
$9.73M Buy
206,804
+182,562
+753% +$7.51M 0.01% 471
2018
Q1
$877K Buy
+24,242
New +$853K ﹤0.01% 568
2017
Q3
Sell
-7,026
Closed -$291K 689
2017
Q2
$291K Buy
+7,026
New +$267K ﹤0.01% 629

Other funds holding RGEN

Jennison Associates's RGEN Position: Q1 2026 in Review

Jennison Associates reduced its Repligen (RGEN) stake by 1.9% in Q1 2026, selling an estimated $330K and leaving 121,239 shares worth $14.3M. The position accounts for 0.01% of the portfolio, ranked #355.

Jennison Associates first reported a position in RGEN in Q2 2017 and has held it in 21 quarters since. The position peaked at $37.5M in Q1 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Jennison Associates held 121,239 shares of Repligen worth $14.3M as of Q1 2026.
  • Jennison Associates sold 2,361 Repligen shares in Q1 2026, an estimated $330K.
  • Repligen made up 0.01% of Jennison Associates's portfolio in Q1 2026, its #355 holding.
  • Jennison Associates first reported a position in Repligen in Q2 2017 and has held it in 21 quarters since.
  • Jennison Associates's Repligen position peaked at $37.5M in Q1 2021.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Jennison Associates's 13F filing for Q1 2026, filed 6 May 2026.